At a Glance
| Midazolam | 1,4-Butanediol | |
|---|---|---|
| Class | Depressant | Depressant |
| Common Dose (oral) | 5–15 mg | 1–2.5 mL |
| Total Duration | 2–4 hrs | 1.3–3 hrs |
| Routes | intravenousoral | oral |
Dangerous Combination
Combining Midazolam and 1,4-Butanediol is classified as dangerous. Combined CNS depression; risk of respiratory failure
Midazolam, a Depressant, and 1,4-Butanediol, a Depressant, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Depressants, meaning they share a common pharmacological foundation. They share 8 documented effects in common, with 1 effects unique to Midazolam and 6 unique to 1,4-Butanediol. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Midazolam | 1,4-Butanediol | |
|---|---|---|
| Class | Depressant | Depressant |
| Common Dose (oral) | 5–15 mg | 1–2.5 mL |
| Total Duration | 2–4 hrs | 1.3–3 hrs |
| Routes | intravenousoral | oral |
| Effects | 9 documented | 14 documented |
| Interaction | Dangerous | |
| Level | Midazolam | 1,4-Butanediol |
|---|---|---|
| Threshold | 1 mg | 0.5 mL |
| Light | 2.5–5 mg | 0.5–1 mL |
| Common | 5–15 mg | 1–2.5 mL |
| Strong | 15–30 mg | 2.5–4 mL |
| Heavy | 30 mg | 4 mL |
| Level | Dose |
|---|---|
| Threshold | 1 mg |
| Light | 1–2 mg |
| Common | 2–4 mg |
| Strong | 4–5 mg |
| Heavy | 5 mg |
Midazolam
1,4-Butanediol
Combined CNS depression; risk of respiratory failure